Bank of America’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-135,000
Closed -$6.31M 7867
2021
Q1
$6.31M Hold
135,000
﹤0.01% 3169
2020
Q4
$5.88M Buy
+135,000
New +$4.98M ﹤0.01% 2984

Other funds holding HCAT

Bank of America's HCAT Position: Q1 2026 in Review

Bank of America reduced its Health Catalyst (HCAT) stake by 48% in Q1 2026, selling an estimated $164K and leaving 95,730 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #5490.

Bank of America first reported a position in HCAT in Q3 2019 and has held it in 27 quarters since. The position peaked at $13.6M in Q2 2021. 131 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Bank of America held 95,730 shares of Health Catalyst worth $122K as of Q1 2026.
  • Bank of America sold 87,077 Health Catalyst shares in Q1 2026, an estimated $164K.
  • Health Catalyst made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5490 holding.
  • Bank of America first reported a position in Health Catalyst in Q3 2019 and has held it in 27 quarters since.
  • Bank of America's Health Catalyst position peaked at $13.6M in Q2 2021.
  • 131 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.